FCare announce the introduction of their new HPR45i probes

FCare announce the introduction of their new HPR45i probes designed for and proven in the clinical treatment of Haemorrhoids.

“This new and improved method is easy to use and very effective on Haemorrhoids degree 1 – 4. Treatments can be done over several 15-20 minute sessions under local anesthesia. Patients hardly experience any pain post treatment so minimal postoperative care is required and a swift return to normal daily activity is possible. Clinical trials with this revolutionary method have been conducted by Dr Kłos and Dr Batijewski in the Kriocentrum in Otwock, Poland, on 160 patients and have proven the effectiveness of the HPR45i probe. The average number of sessions was 2 – 3 with a 95% reduction of the treated hemorrhoids. Most patients were very satisfied with the treatment and their instant relief of pain. They were able to return to their normal activities within 24 hours after the treatment”.

Whilst most vascular practitoners of the EVRF device might not conduct Haemorrhoid treatments, to have it available as yet another function of the device within a clinic or hospital facility simply adds to the value of the unit. Click here for initial study results.

Modern Aesthetic Solutions will be presenting the EVRF device at the Vacular Society AGM from 28th to 30th November 2012.

Modern Aesthetic Solutions will be presenting the EVRF device at the Vacular Society AGM from 28th to 30th November 2012.

Dr Attila Szabó MD, PhD of the Semmelweis University Budapest, Hungary has recently completed a trial using the EVRF

Dr Attila Szabó MD, PhD of the Semmelweis University Budapest, Hungary has recently completed a trial using the EVRF.

Between July 2011 and September 2012 he treated 150 patients, recording 149 of those as having witnessed total occlusion of the Saphenous Vein. He concluded that the EVRF saphenous ablation is a safe, painless procedure for the treatment of the reflux of the GSV and/or SSV with high patient acceptance and minimal postoperative discomfort allows the quick return to work and normal life.

Dr Lars Rasmussen, Denmark, following a recent study comparing all endovenous procedures, has reported that “EVRF is one of the thermo-ablation methods with the lowest pain score”.

Dr Lars Rasmussen, Denmark, following a recent study comparing all endovenous procedures, has reported that “EVRF is one of the thermo-ablation methods with the lowest pain score”.

EVRF is now being offered by Mr Paul Burke at Barringtons Private Hospital, Limerick, Eire.

EVRF is now being offered by Mr Paul Burke at Barringtons Private Hospital, Limerick, Eire.

Daily Mail Reporter, Angela Epstein, compares different options for varicose vein treatment

Daily Mail Reporter, Angela Epstein, compares different options for varicose vein treatment but the report concludes that most have their uses and good practice is to be able to offer a variety of techniques. She comments on the use of Radio Frequency, the basis of the EVRF device,

“With local anaesthetic, a thin catheter is inserted into the vein, then radiofrequency current is used to collapse the vein walls. The technique, called radio-frequency ablation, is very similar to laser in terms of application, though not as successful. Stockings usually need to be worn for ten to 14 days, as these hold the vein area in place, making it more comfortable for the patient”.

ADVANTAGES: This targets the vein more accurately than laser treatment, says Mr Scurr. This means less chance of burning the tissues around the vein and so less risk of scarring and nerve damage, and slightly less pain. It’s good for early varicose veins rather than bulging ones on the lower part of the leg.

DISADVANTAGES: Slightly higher failure rate than endovenous laser ablation but still more than 90 per cent successful, says Mr Chaloner.

We are soon to be introducing a new proprietary needle

We are soon to be introducing a new proprietary needle specifically designed to treat the blue mid-sized multi-directional veins on the legs where several veins seem to merge superficially giving an unsightly, often raised, appearance. These are usually the recidivism from previous sclerotherapy treatments. If successful, these may avoid the use of foam sclerotherapy in the future. We hope to have clinical evidence available by October 2012.

Mr Paul Burke, Consultant Surgeon at St. Johns Hospital, Limmerick, is now offering EVRF treatments

Mr Paul Burke, Consultant Surgeon at St. Johns Hospital, Limmerick, is now offering the EVRF treatment to his patients. He tells us that with the ease of use and lack of concerns associated with the laser alternatives, coupled with the significant cost savings achieved in comparison to similar treatments, the EVRF seemingly provides a perfect solution.

Spire Hospitals are offering the EVRF treatment from their Manchester and Regency hospitals

We are delighted to announce that Spire Hospitals are offering the EVRF treatment from their Manchester and Regency hospitals. Under the direction of Mr Ferdinand Serracino-Inglott, Consultant Surgeon, saphenous treatments using EVRF are being performed with great success.

Today we presented the EVRF at the Charing Cross Symposium at Imperial College

Today we presented the EVRF at the Charing Cross Symposium at Imperial College, London, to great applause. In conjunction with FCare Systems, its manufacturer, we welcomed the enthusiam shown by so many in the vascular field and we look forward to attending their clinics in due course so that we can show them the extent of treatment which EVRF offers, coupled with its proven efficacy.